Takeda joins with Xavier University to increase equity in healthcare

Pharmaceutical company Takeda has announced a multi-year, multi-million dollar investment that is aimed at furthering health equity in New Orleans. Through a grant provided to top HBCU Xavier University of Louisiana, the program will support the development of a technical research and exchange center (T-REX) that will accelerate Xavier’s health informatics, research findings, and interventions at the intersection of science, clinical practice, and data. To learn more about the grant and the ambitious goals of the collaboration partners, Outsourcing-Pharma spoke with:

  • Anne McCall, provost and senior vice president for academic affairs at Xavier University of Louisiana
  • Lauren Powell, MPA, PhD, vice president of US health equity and community wellness at Takeda

OSP: Could you please share how Xavier and Takeda came to work together? Have the two worked together on any projects before?

LP: We chose to partner specifically with Xavier University of Louisiana on this initiative given their long-standing history of improving the community of New Orleans, and their trustworthiness within the community to be able to understand the need to make a real impact and drive sustainable change.

Xavier’s geographic location also represents a region of great unmet need in healthcare. Louisiana has sat at or near the bottom of nearly every measurable health metric, ranking well below the national average for years. Currently, they are ranked 50th in health outcomes ratings. New Orleans’ national health ranking has improved over the last decade, but health disparities among the city’s minority groups continue to fall below national averages in life expectancy, including higher rates of adverse childhood experiences, food insecurity, premature death, chronic and preventable illnesses.


Leave a Reply

Your email address will not be published.